ALI SAFDAR: Open Payments
NPI 1043211303 · MARION, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 20 payments from 8 companies in 2025. Trend: 2023 $344 · 2024 $320 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $103 |
| Alkermes, Inc. | 4 | $76 |
| Neurocrine BioSciences, Inc. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| ABBVIE INC. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: FANAPT, ARISTADA, INGREZZA, REXULTI, VRAYLAR, INVEGA SUSTENNA, CAPLYTA, Jornay PM.
Industry payments across IA — which companies pay providers there.
